A group of SFU researchers have collaborated with colleagues internationally to provide insight into the “mutational landscape” of a rare type of fatal liver cancer, which may allow them to identify its cause and improve its diagnosis and treatment. Intrahepatic cholangiocarcinoma (ICC) or intrahepatic bile duct cancer, while only observed in five to 10 per cent of those with primary liver cancer, is very dangerous for those affected. This is because it is based in the bile duct, where it is unlikely to be detected. A lack of diagnostic tools make it difficult to form a conclusive diagnosis in the…
Continue reading
